Bristol-Myers Squibb Stock BMY

For the second time in a year and a half, clinical trials of the Opdivo drug failed to impress and the stock collapsed. On Mon Apr 16 2018 the loss was 8%. In August 2016 it was 16%.

These types of stock declines can damage a portfolio and rarely are there any warning signs.

That though does not mean investors are at the mercy of the market. This short article looks at how an investor can protect their trade against market gyrations and stock collapses through a very simple method.

 This Bristol-Myers Squibb Stock article is for FullyInformed Members.

Bristol-Myers Squibb Stock – Apr 16 2018



 Internal Stock and Option Trades Links

Portfolio Listing by Years

My Principal Stocks Index

Trade Ideas for Members

Trade Alerts for Members

Put Selling Strategies

Put Selling Strategies For Members

Covered Calls Strategies

Covered Calls Strategies For Members

Profit And Income Strategies Index

Stock and Option Strategies For Members

Stock And Option Trades Explained For Members

Ask A Question About A Trade You Are In

Sign My Guestbook

Visit My Shop

Join The Free Options Forum